Search for: "McNamara v. McNamara" Results 101 - 120 of 192
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Oct 2007, 7:04 am
The same issue was bypassed in McNamara v. [read post]
15 Apr 2010, 7:24 am by Andres
Harmon, pp.226-229 Gene Cartels: Biotech Patents in The Age of Free Trade, By Luigi Palombi, Reviewed by David Koepsell, pp.230-231 Reputation, Celebrity and Defamation Law, By David Rolph, Reviewed by Lawrence McNamara, pp.232-235 Law, Mind And Brain, By Michael Freeman and Oliver R Goodenough (eds), Reviewed by Dennis Patterson, pp.236-241 [read post]
7 Dec 2017, 4:00 am by Administrator
See also R v R (BS), supra note 108. 203 See R v B (R) (2005), 77 OR (3d) 171, 202 OAC 115, 66 WCB (2d) 462 at para 28 (CA). 204 R v McNamara et al (No 1) (1981), 56 CCC (2d) 193 at 346-49 (Ont CA), leave to appeal to SCC refused (1981), 56 CCC (2d) 576; R v W (LK) (1999), 138 CCC (3d) 449, 126 OAC 39 at para 69 (CA); R v Brown (1999), 137 CCC (3d) 400, 27 CR (5th) 151, 123 OAC 258 at para 32 (CA). 205 See R v McNamara et al (No… [read post]
21 Sep 2018, 12:30 pm by John K. Ross
Sacred pachyderms, boating while Latino, and police misconduct insurance.Over at the Cato Institute's Daily Podcast, IJ Senior Attorney Robert McNamara explains why the Supreme Court's recent decision in NIFLA v. [read post]
8 Sep 2011, 7:12 am by FDABlog HPM
  As we recently reported, the Proposed PDUFA V Reauthorization Performance Goals and Procedures for Fiscal Years 2013 through 2017 includes an initiative, styled as “Advancing Development of Drugs for Rare Diseases,” that would require FDA to, among other things, “develop and implement staff training related to development, review, and approval of drugs for rare diseases. [read post]
23 Feb 2010, 9:56 pm by Josh Wright
  In another famous example, economist Alfred Kahn was appointed in New York v. [read post]